Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

The Lancet Infectious Diseases

Volumn 9, Issue 12, 2009, Pages 789-795

  Verweij, Paul E ^a   Snelders, Eveline ^a   Kema, Gert HJ ^b   Mellado, Emilia ^c   Melchers, Willem JG ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE; DIFENOCONAZOLE; ENILCONAZOLE; FLUSILAZOLE; FUNGICIDE; ITRACONAZOLE; MYCLOBUTANIL; POSACONAZOLE; PROCHLORAZ; PROPICONAZOLE; PYRROLE DERIVATIVE; TEBUCONAZOLE; TRIADIMENOL; TRIFLUMIZOLE; TRIFUMIZOL; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMPOST; CROSS RESISTANCE; ENVIRONMENTAL EXPOSURE; GENETIC RESISTANCE; HUMAN; INSECTICIDE RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SOIL; TANDEM REPEAT;

EID: 71549143158     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(09)70265-8     Document Type: Note

References (54)

1. Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52 (2009) 197-205
2. Einsele H., Quabeck K., Müller K.D., et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet 352 (1998) 1443
3. Sarfati J., Monod M., Recco P., et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 55 (2006) 279-291
4. Patterson J.E., Zidouh A., Miniter P., Andriole V.T., and Patterson T.F. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 18 (1997) 104-108
5. Keating M.R., Guerrero M.A., Daly R.C., Walker R.C., and Davies S.F. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 109 (1996) 1119-1124
6. Pegues D.A., Lasker B.A., McNeil M.M., et al. Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis 34 (2002) 412-416
7. Walsh T.J., Anaissie E.J., Denning D.W., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 (2009) 327-360
8. Cornely O.A., Maertens J., Winston D.J., et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356 (2007) 348-359
9. Ullmann A.J., Lipton J.H., Vesole D.H., et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356 (2007) 335-347
10. Cowen L.E. Predicting the emergence of resistance to antifungal drugs. FEMS Microbiol Lett 204 (2001) 1-7
11. Howard S.J., Webster I., Moore C.B., et al. Multi-azole resistance in Aspergillus fumigatus. Intern J Antimicrob Agents 28 (2006) 450-453
12. Chen J., Li H., Li R., Bu D., and Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 55 (2005) 31-37
13. Howard S.J., Cerar D., Anderson M.J., et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15 (2009) 834-836
14. Verweij P.E., Mellado E., and Melchers W.J.G. Multiple-triazole-resistant aspergillosis. N Engl J Med 356 (2007) 1481-1483
15. Snelders E., van der Lee H., Kuijpers J., et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5 (2008) e219
16. Verweij P.E., Te Dorsthorst D., Rijs A., De Vries-Hospers H.G., and Meis J.F.G.M. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J Clin Microbiol 40 (2002) 2648-2650
17. Warris A., Weemaes C.M., and Verweij P.E. Multidrug resistance in Aspergillus fumigatus. N Engl J Med 347 (2002) 2173-2174
18. van Leer-Buter C., Takes R.P., Hebeda K.M., Melchers W.J., and Verweij P.E. Aspergillosis-and a misleading sensitivity result. Lancet 370 (2007) 102
19. Hodiamont C.J., Dolman K.M., ten Berge R.J.M., et al. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with longterm oral posaconazole and surgery. Med Mycol 47 (2009) 217-220
20. Van der Linden J.W.M., Jansen R.R., Bresters D., et al. Azole-resistant central nervous system aspergillosis. Clin Infect Dis 48 (2009) 1111-1113
21. Anderson J.B. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3 (2005) 547-556
22. Lamb B.C., Mandaokar S., Bahsoun B., Grishkan I., and Nevo E. Differences in spontaneous mutation frequencies as a function of environmental stress in soil fungi at "Evolution Canyon," Israel. Proc Natl Acad Sci USA 105 (2008) 5792-5796
23. Trösken E.R., Bittner N., and Volkel W. Quantitation of 13 azole fungicides in wine samples by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1083 (2005) 113-119
24. Oestreich A., Schmid P., and Schlatter C. Biological monitoring of the fungicide epoxiconazol during application. Arch Environ Contam Toxicol 33 (1997) 329-335
25. European Commission, Health and Consumer Protection Directorate-General. Opinion on azole antimycotic resistance, adopted by the Scientific Steering Committee at its meeting of 27-28 June 2002. http://ec.europa.eu/food/fs/sc/ssc/out278_en.pdf (accessed Oct 20, 2009).
26. LEI. Landen tuinbouwcijfers 2004 (2004), LEI, The Hague. http://www.lei.dlo.nl/publicaties/PDF/2004/PR_xxx/PR_04_02.pdf (accessed Nov 3, 2009).
27. Ji H., Zhang W., Zhou Y., et al. A three-dimensional model of lanosterol 14α-demethylase of Candida albicans and its interaction with azole antifungals. J Med Chem 43 (2000) 2493-2505
28. Hamamoto H., Hasegawa K., Nakaune R., et al. Tandem repeat of a transcriptional enhancer upstream of the sterol 14α-demethylase gene (CYP51) in Penicillium digitatum. Appl Environ Microbiol 66 (2000) 3421-3426
29. Ghosopha J.M., Schmidt L.S., Margosan D.A., and Smilanick J.L. Imazalil resistance linked to a unique insertion sequence in the PdCYP51 promoter region of Penicillium digitatum. Postharv Biol Technol 44 (2007) 9-18
30. Ma Z., Proffer T.J., Jacobs J.L., and Sundin G.W. Overexpression of the 14α-demethylase target gene (CYP51) mediates fungicide resistance in Blumeriella jaapii. Appl Environ Microbiol 72 (2006) 2581-2585
31. Delye C., Laigret F., and Corio-Costet M.-F. Mutation in the 14α-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor. Appl Environ Microbiol 63 (1997) 2966-2970
32. Délye C., Bousset L., and Corio-Costet M.F. PCR cloning and detection of point mutations in the eburicol 14α-demethylase (CYP51) gene from Erysiphe graminis f sp hordei, a "recalcitrant" fungus. Curr Genet 34 (1998) 399-403
33. Cools H.J., Fraaije B.A., Kim S.H., and Lucas J.A. Impact of changes in the target P450 CYP51 enzyme associated with altered triazole-sensitivity in fungal pathogens of cereal crops. Biochem Soc Trans 34 (2006) 1219-1222
34. Fraaije B.A., Cools H.J., Kim S.H., Motteram J., Clark W.S., and Lucas J.A. A novel substitution I381V in the sterol 14-α demethylase (Cyp51) of Mycosphaerella graminicola is differentially selected by azole fungicides. Mol Plant Pathol 8 (2007) 245-254
35. Leroux P., Albertini C., Gautier A., Gredt M., and Walker A.S. Mutations in the CYP51 gene correlated with changes in sensitivity to sterol 14 alpha-demethylation inhibitors in field isolates of Mycosphaerella graminicola. Pest Manag Sci 63 (2007) 688-698
36. Luo C., Cox K.D., Amiri A., and Schnabel G. Occurrence and detection of the DMI resistance-associated genetic element 'Mona' in Monilinia fructicola. Plant Dis 92 (2008) 1099-1103
37. Schnabel G., and Jones A.L. The 14 α-demethylase (CYP51A1) gene is overexpressed in Venturia inaequalis strains resistant to myclobutanil. Phytopathol 91 (2001) 102-110
38. Wyand R.A., and Brown J.K. Sequence variation in the CYP51 gene of Blumeria graminis associated with resistance to sterol demethylase inhibiting fungicides. Fungal Genet Biol 42 (2005) 726-735
39. Butters J.A., Zhou M.C., and Hollomon D.W. The mechanism of resistance to sterol 14α-demethylation inhibitors in a mutant (Erg40) of Ustilago maydis. Pest Manag Sci 56 (2000) 257-263
40. Albertini C., Gredt M., and Leroux P. Polymorphism of 14α-demethylase gene (CYP51) in the cereal eyespot fungi Tapesia acuformis and Tapesia yallundae. Eur J Plant Pathol 109 (2003) 117-128
41. Diaz-Guerra T.M., Mellado E., Cuenca-Estrella M., and Rodriguez-Tudela J.L. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 47 (2003) 1120-1124
42. Mellado E., Garcia-Effron G., Alcazar-Fuoli L., Cuenca-Estrella M., and Rodriguez-Tudela J.L. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 48 (2004) 2747-2750
43. Manavathu EK, Baskaran I, K rishnan S, Alangaden G, Chandrasekar PH. Cytochrome P450 14-alpha-sterol demethylase mutation dependent triazole cross-resistance in Aspergillus fumigatus. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA; Sept 14-17, 2003. Abstract M-392.
44. Mellado E., Garcia-Effron G., Alcazar-Fuoli L., et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51 (2007) 1897-1904
45. Verweij P.E., Howard S.J., Melchers W.J.G., and Denning D.W. Azole resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Update (2009) 10.1016/j.drup.2009.09.002 published online Oct 29.
46. O'Gorman C.M., Fuller H.T., and Dyer P.S. Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature 457 (2009) 471-474
47. Hof H. Critical annotiations to the use of azole antifungals for plant protection. Antimicrob Agents Chemother 45 (2001) 2987-2990
48. Hof H. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?. Drug Resist Update 11 (2008) 25-31
49. Meneau I., and Sanglard D. Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. Med Mycol 43 suppl 1 (2005) S307-S311
50. Snelders E., Huis in 't Veld H., Rijs A., Kema G.H.J., Melchers W.J.G., and Verweij P.E. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 75 (2009) 4053-4057
51. Serfling A., Wohlrab J., and Deising H.B. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. Antimicrob Agents Chemother 51 (2007) 3672-3676
52. Vanni A., Fontana F., Gamberini R., and Calabria A. Occurrence of dicarboximide fungicides and their metabolites' residues in commercial compost. Argonomie 24 (2004) 7-12
53. Howard S.J., Pasqualotto A.C., and Denning D.W. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect (2009) 10.1111/j.1469-0691.2009.02911.x published online Aug 7, 2009.
54. Lagrou K, De Vleeschouwer J, Meerseman W, et al. Triazole resistance among 229 clinical Aspergillus fumigatus isolates. Proceedings of the 3rd Advances Against Aspergillosis Meeting, Miami, FL, USA; Jan 16-19, 2008. Abstract 33.